JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide. [electronic resource]
Producer: 20190219Description: 7433 p. digitalISSN:- 2045-2322
- Animals
- Cell Adhesion Molecules -- genetics
- Cell Line, Tumor
- Disease Progression
- Epithelial-Mesenchymal Transition -- drug effects
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Lenalidomide -- administration & dosage
- Lymphatic Metastasis
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Mice
- Neoplasm Invasiveness
- Nodal Protein -- metabolism
- Prognosis
- Receptors, Cell Surface -- genetics
- Signal Transduction -- drug effects
- Transforming Growth Factor beta -- metabolism
- Up-Regulation -- drug effects
- Xenograft Model Antitumor Assays
- Zebrafish
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.